Date: 09/26/2019
HERCULES, CA – September 26, 2019 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products issued a statement related to critical security vulnerabilities recently reported in the VxWorks real-time operating system.
VxWorks is used in hardware instrumentation such as patient monitors, industrial controllers, robotics, firewalls, routers, modems and printers. These vulnerabilities are referred to as "URGENT/11."Bio-Rad has investigated our Clinical Diagnostics products. None of our instruments are affected. We are still investigating whether there is an impact on any peripherals that Bio-Rad offers (e.g. printers and firewall) as accessories to our instruments.
Bio-Rad recommends that customers check the specific models of these peripherals that are used by the lab. Customers are advised to consult the manufacturer's website for more information regarding URGENT/11.
Bio-Rad is fully committed to monitoring the performance of its products and improving the quality of services. It is our highest priority to maintain customer satisfaction. If you have any questions or concerns, please contact your local
Please reenter your email address in the correct format.
Please enter your email address.
Your subscription information already exists, we will send you an email with specific instructions to manage your existing subscription profile.
To receive the latest news, promotions, and more, sign up for Bio-Rad updates by entering your email address below. You can elect to receive only the types of Bio-Rad communications that are of interest to you..
Call us at 00 800 00 BIORAD (00 800 00 24 67 23) or +351 21 47 27 717
Our Products
Home |
Trademarks |
Site Terms |
Terms & Conditions |
Imprint |
EU Recycle Program |
Privacy
|
Change Cookie Setting
© 2020 Bio-Rad Laboratories, Inc.
Your Privacy Matters
Before you visit, we want to let you know we use cookies to offer you a better browsing experience. To learn more about how we use cookies, please review our Cookie Policy, accessible from the Manage Preferences link below. We would appreciate your confirmation by either accepting all cookies or by declining and managing your cookie preferences under the Manage Preferences link below.
Please make a selection